The intracellular bacterial pathogen Coxiella burnetii secretes an effector protein, CbEPF1, which manipulates LD metabolism ...

A pair of studies examining immune response in C. elegans reveal broad implications for understanding pathogen detection in ...

In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the ...

In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the ...

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted ...

The study reveals that moderate fever enhances CD4 T cell activity while reducing regulatory T cell suppression, highlighting ...

Discover Molecular Templates Inc.'s groundbreaking patent for Shiga toxin effector polypeptides, designed for targeted therapies with reduced immune responses in cancer and infections.

The body increases temperature to fight off infections and illness. This temporary increase in temperature, also known as a ...

Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced today an expansion in ...

Investigational immunotherapy candidate, VTP-1000, seeks to address significant unmet need in people with celiac disease.An estimated one in 100 ...

SeromYx Systems, a cutting-edge immunology technology company, and ACROBiosystems, an innovative provider for life science solutions and tools, are excited to announce the release of their joint study ...

Pathogenic activating point mutations in the LRRK2 kinase cause autosomal-dominant familial Parkinsońs disease (PD). In cultured cells, mutant LRRK2 causes a deficit in de novo cilia formation and ...